News
NEWS
-
R&DCelaid Therapeutics Advances to NEDO DTSU PCA Phase, Scaling HSC platform for Global Cell and Gene Therapy Manufacturing
-
newsCelaid Wins Multiple Awards at the Final Round of the Healthcare & Medical Venture Awards
-
newsCelaid Therapeutics to Participate in the Biotech Showcase 2026 in San Francisco During JPM Week
-
newsCelaid Therapeutics to Present at RESI JPM 2026 (San Francisco, USA)
-
newsSelected as a participating company in LabCentral's “Next Phase Program”
-
newsWinner of the Health and Medical Venture Grand Prize (Drug Discovery & SaMD League)
-
newsJoining the Shonan Health Innovation Conference (SHIC) in Boston
-
R&D
Core patents for albumin-free, serum-free HSC expansion method allowed in Japan
-
newsJoining the 2025 AABB/Cord Blood Connect in San Diego